http://orcid.org/0000-0001-5536-4192
Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Upasana Bondopadhyay, Jane McGrath & Andrew N. Coogan. (2023) “Tell Me More About Your Child’s Sleep”: A Qualitative Investigation Of Sleep Problems In Children With ADHD. Behavioral Sleep Medicine 0:0, pages 1-10.
Read now
Read now
Lena Xiao, Anna Chen, Arpita Parmar, Lucy Frankel, Alene Toulany, Brian J. Murray & Indra Narang. (2022) Narcolepsy Treatment: Voices of Adolescents. Behavioral Sleep Medicine 20:2, pages 260-268.
Read now
Read now
Ann C. Childress, Nathalie Beltran, Carl Supnet & Margaret D. Weiss. (2021) Reviewing the role of emerging therapies in the ADHD armamentarium. Expert Opinion on Emerging Drugs 26:1, pages 1-16.
Read now
Read now
Articles from other publishers (26)
Wei Wei, Li Chen, Hui Zhou, Jinfeng Liu, Yue Zhang, Shiyu Feng, Yingtao Bai, Yanen Leng, En Chang & Liang Huang. (2023) Safety profiles of methylphenidate, amphetamine, and atomoxetine: analysis of spontaneous reports submitted to the food and drug administration adverse event reporting system. Frontiers in Pharmacology 14.
Crossref
Crossref
Hailey M Kindt, Wen-Jan Tuan & Curtis W Bone. (2023) Do prescription stimulants increase risk of Parkinson’s disease among adults with attention-deficit hyperactivity disorder? A retrospective cohort study. Family Practice.
Crossref
Crossref
Johnny L. Matson. 2023. Clinical Handbook of ADHD Assessment and Treatment Across the Lifespan. Clinical Handbook of ADHD Assessment and Treatment Across the Lifespan
649
658
.
Jeff Schein, Martin Cloutier, Marjolaine Gauthier-Loiselle, Rebecca Bungay, Annie Guerin & Ann Childress. (2022) Reasons for Treatment Changes in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Chart Review Study. Advances in Therapy 39:12, pages 5487-5503.
Crossref
Crossref
Miriam Kessi, Haolin Duan, Juan Xiong, Baiyu Chen, Fang He, Lifen Yang, Yanli Ma, Olumuyiwa A. Bamgbade, Jing Peng & Fei Yin. (2022) Attention-deficit/hyperactive disorder updates. Frontiers in Molecular Neuroscience 15.
Crossref
Crossref
Shannon Brumbaugh, Wen Jan Tuan, Alyssa Scott, James R. Latronica & Curtis Bone. (2022) Trends in characteristics of the recipients of new prescription stimulants between years 2010 and 2020 in the United States: An observational cohort study. eClinicalMedicine 50, pages 101524.
Crossref
Crossref
Ann C. Childress. (2022) Stimulants. Child and Adolescent Psychiatric Clinics of North America 31:3, pages 373-392.
Crossref
Crossref
M.S. Kahrizi, K. Ghanbari Mardasi, P. Ghanbari Merdasi & M. Assareh. (2022) Prevalence of tics among attention deficit hyperactivity disorder children treated with methylphenidate. Neuropsychiatrie de l'Enfance et de l'Adolescence 70:3, pages 117-121.
Crossref
Crossref
Marco Antônio Arruda, Renato Arruda, Vicenzo Guidetti, Marcelo Eduardo Bigal, Jesus Landeira-Fernandez, Anna C. Portugal & Luis Anunciação. (2022) Associated Factors of Attention-Deficit/Hyperactivity Disorder Diagnosis and Psychostimulant Use: A Nationwide Representative Study. Pediatric Neurology 128, pages 45-51.
Crossref
Crossref
Huiya Mei, Ruijin Xie, Tianxiao Li, Zongxin Chen, Yueying Liu & Chenyu Sun. (2022) Effect of Atomoxetine on Behavioral Difficulties and Growth Development of Primary School Children with Attention-Deficit/Hyperactivity Disorder: A Prospective Study. Children 9:2, pages 212.
Crossref
Crossref
Pei-Yin Pan, Ulf Jonsson, Sabriye Selin Şahpazoğlu Çakmak, Alexander Häge, Sarah Hohmann, Hjalmar Nobel Norrman, Jan K. Buitelaar, Tobias Banaschewski, Samuele Cortese, David Coghill & Sven Bölte. (2021) Headache in ADHD as comorbidity and a side effect of medications: a systematic review and meta-analysis. Psychological Medicine 52:1, pages 14-25.
Crossref
Crossref
Ke Ning & Tingzhao Wang. (2021) Multimodal Interventions Are More Effective in Improving Core Symptoms in Children With ADHD. Frontiers in Psychiatry 12.
Crossref
Crossref
Lanliu Deng, Ping Zhou, Lin Zhu, Yu Zhang, Ting Yang, Qiuxia Zhao, Jie Chen, Tingyu Li, Qian Cheng & Li Chen. (2021) Methylphenidate and atomoxetine treatment negatively affect physical growth indexes of school-age children and adolescents with attention-deficit/hyperactivity disorder. Pharmacology Biochemistry and Behavior 208, pages 173225.
Crossref
Crossref
Yu-Shu HuangChin-Bin YehChin-Hung ChenChi-Yung ShangSusan Shur-Fen Gau. (2021) A Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Clinical Trial of ORADUR-Methylphenidate for Treating Children and Adolescents with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology 31:3, pages 164-178.
Crossref
Crossref
Brayden Kameg & Dina Fradkin. (2021) Management of Attention-Deficit/Hyperactivity Disorder in Adults. The Journal for Nurse Practitioners 17:4, pages 432-436.
Crossref
Crossref
Anna Sierawska, Alexander Prehn-Kristensen, Hannah Brauer, Kerstin Krauel, Carolin Breitling-Ziegler, Michael Siniatchkin & Alena Buyx. 2021. Non-invasive Brain Stimulation (NIBS) in Neurodevelopmental Disorders. Non-invasive Brain Stimulation (NIBS) in Neurodevelopmental Disorders
363
386
.
Miriam Sanabra, Tary Gómez-Hinojosa, Carlota Alcover, Oscar Sans & Jose A. Alda. (2020) Effects of stimulant treatment on sleep in attention deficit hyperactivity disorder (ADHD). Sleep and Biological Rhythms 19:1, pages 69-77.
Crossref
Crossref
. (2020) ADHD-Relevant Motor and Cognitive Effects of a Fixed-Dose Combination of
Caffeine, Gingko Biloba and β-Phenethylamine (PEA). Journal of Clinical Review & Case Reports 5:4.
Crossref
Crossref
Kanchana KoonrungsesomboonNut Koonrungsesomboon. (2020) The Effects of Methylphenidate Treatment on Child Growth in Thai Children and Adolescents with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology 30:3, pages 189-197.
Crossref
Crossref
Felipe Almeida Picon, João Ricardo Sato, Maurício Anés, Leonardo Modesti Vedolin, Alessandro André Mazzola, Bruna Bressan Valentini, Renata Basso Cupertino, Rafael Gomes Karam, Marcelo Moraes Victor, Vitor Breda, Katiane Silva, Neivo da SilvaJrJr, Claiton Henrique Dotto Bau, Eugenio Horacio Grevet & Luis Augusto Paim Rohde. (2018) Methylphenidate Alters Functional Connectivity of Default Mode Network in Drug-Naive Male Adults With ADHD. Journal of Attention Disorders 24:3, pages 447-455.
Crossref
Crossref
Hironobu IchikawaTasuku MiyajimaYushiro YamashitaMasakazu FujiwaraAkimasa FukushiKazuhiko Saito. (2019) Phase II/III Study of Lisdexamfetamine Dimesylate in Japanese Pediatric Patients with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology.
Crossref
Crossref
Donald E. Greydanus, Kevin W. Cates & Nina Sadigh. (2019) Adverse effects of stimulant medications in children and adolescents: focus on drug abuse. International Journal of Adolescent Medicine and Health 31:4.
Crossref
Crossref
Anna Sierawska, Alexander Prehn-Kristensen, Vera Moliadze, Kerstin Krauel, Rafal Nowak, Christine M. Freitag, Michael Siniatchkin & Alena Buyx. (2019) Unmet Needs in Children With Attention Deficit Hyperactivity Disorder—Can Transcranial Direct Current Stimulation Fill the Gap? Promises and Ethical Challenges. Frontiers in Psychiatry 10.
Crossref
Crossref
Theodora A. Manolis, Antonis A. Manolis & Antonis S. Manolis. (2018) Cardiovascular Safety of Psychiatric Agents: A Cautionary Tale. Angiology 70:2, pages 103-129.
Crossref
Crossref
Stephen M. Stahl. 2021. Prescriber's Guide – Children and Adolescents. Prescriber's Guide – Children and Adolescents.
John S. Carlson, Danielle Haggerty & Sally Askar. 2018. Handbook of Pediatric Behavioral Healthcare. Handbook of Pediatric Behavioral Healthcare
171
184
.